Study backs use of new heart risk tool

A cardiovascular risk assessment tool specific to the UK population has proved its worth in an independent validation study of more than a million UK patients, say its developers.

Compared with Framingham, the tool developed in the US in the 1970s and still used in the UK, QRISK was better at classifying patients into high or low categories of cardiovascular risk. This is important when deciding if people have a 20 per cent risk of a cardiovascular event in 10 years, thereby making them eligible for statin therapy.

QRISK also differs from Framingham by taking deprivation into account.

Depending on a NICE guideline, QRISK could be used instead of Framingham across the UK to assess cardiovascular risk.

Lead researcher Dr Peter Brindle, a GP and research and development lead for Bristol PCT, said: 'There will be a large number of people willing to use QRISK because of problems with health inequalities in the UK. Continuing to use Framingham could exacerbate health inequalities.'

Kent GP Dr Rubin Minhas, CHD lead for Medway PCT, said: 'QRISK could prevent thousands being unnecessarily treated. But, independent evaluation by NICE is needed.'

rachel.liddle@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in


Just published

Young doctor

BMA poll could see 'demeaning' junior doctor title ditched

The BMA could drop the term 'junior doctor' in favour of 'resident doctor' to better...

Houses of parliament

Tory peer calls PA fears 'Luddism' and claims most GP visits 'incredibly straightforward'

Most GP appointments are 'incredibly straightforward' and fears over a wider role...

UK money

NHS pension contribution overhaul to go ahead from April

Changes to NHS pension contribution rates, which will see the top earners required...

BMA sign

BMA warns £800m lost from GP contract since 2019 as last-ditch talks continue

BMA negotiators remain in talks over an improved GP contract offer for 2024/25 just...

GP consultation

GPs still under pressure to prescribe black triangle drug inclisiran

GPs are continuing to face pressure to prescribe the black triangle drug inclisiran...

BMA chair Professor Phil Banfield

Lords urged to block legislation for GMC to regulate PAs

The BMA has urged peers to block legislation that would make the GMC responsible...